Here are four updates on GI companies from the past week:
IntegraGen's miRpredX 31-3p test was awarded a CE mark for use in the European Union.
The FDA awarded Innovate Biopharmaceuticals' INN-108 orphan drug designation.
CapsoVision launched its CapsoCloud, an exam management system.
Chemistry World reported on Takeda's vision for the future; it involves a move away from generics and over-the-counter businesses into pharmaceutical research and development.